Cited by 14Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and MetabolismNatural Antidiabetic Agents Studies

Mechanisms of Artemisia scoparia ’s Anti‐Inflammatory Activity in Cultured Adipocytes, Macrophages, and Pancreatic β‐Cells

Open access
Boudreau, Anik, Burke, Susan J., Collier, J. Jason, Richard, Allison J., Ribnicky, David M., Stephens, Jacqueline M.·2020·Obesity

Abstract

Objective: An ethanolic extract of Artemisia scoparia (SCO) improves adipose tissue function and reduces negative metabolic consequences of high‐fat feeding. A. scoparia has a long history of medicinal use across Asia and has anti‐inflammatory effects in various cell types and disease models. The objective of the current study was to investigate SCO’s effects on inflammation in cells relevant to metabolic health. Methods: Inflammatory responses were assayed in cultured adipocytes, macrophages, and insulinoma cells by quantitative polymerase chain reaction, immunoblotting, and NF‐κB reporter assays. Results: In tumor necrosis factor α–treated adipocytes, SCO mitigated ERK and NF‐κB signaling as well as transcriptional responses but had no effect on fatty acid–binding protein 4 secretion. SCO also reduced levels of deleted in breast cancer 1 protein in adipocytes and inhibited inflammatory gene expression in stimulated macrophages. Finally, in pancreatic β‐cells, SCO decreased NF‐κB–responsive promoter activity induced by IL‐1β treatment. Conclusions: SCO’s ability to promote adipocyte development and function is thought to mediate its insulin‐sensitizing actions in vivo . Our findings that SCO inhibits inflammatory responses through at least two distinct signaling pathways (ERK and NF‐κB) in three cell types known to contribute to metabolic disease reveal that SCO may act more broadly than previously thought to improve metabolic health.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/oby.22912

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • SCO seems to interfere with the inflammatory pathway, reducing metabolic dysfunction, and has a favorable effect on pancreatic β-cells.

    “Furthermore, SCO seems to interfere with the inflammatory pathway, thus reducing metabolic dysfunction, and has a favorable effect on pancreatic β-cells [31].”

    From The Role of Resveratrol Administration in Human Obesity (2021) · cites this paper as [31]

  • Impaired adipocyte differentiation is associated with inflammatory processes in adipose tissue, which are well-known pathogenetic aspects of obesity.

    “Impaired adipocyte differentiation, moreover, is also associated with inflammatory processes in the adipose tissue that are well-known pathogenetic aspects of obesity [31].”

    From The Role of Resveratrol Administration in Human Obesity (2021) · cites this paper as [31]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Boudreau, A., Burke, S. J., Collier, J. J., Richard, A. J., Ribnicky, D. M., & Stephens, J. M.
Affiliations
  • Pennington Biomedical Research Center (US)
  • Rutgers, The State University of New Jersey (US)
Corresponding author
Stephens, Jacqueline M.
Venue
Obesity
Publisher
Wiley
Published
2020-08-02
Volume
28
Issue
9
Pages
1726-1735
ISSN
  • 1930-7381 (ISSN-L)
  • 1930-739X
OpenAlex
W3046515102
Cited by
14
References
50
Citations by year
2026: 3 · 2024: 3 · 2023: 2 · 2022: 3 · 2021: 3
FWCI
1.43
Type
journal article
Language
en
Open access
Locations
  • Obesity (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Civil War Book Review (submittedVersion)
Funders
  • Office of Dietary Supplements (P50 AT002776)
  • National Institutes of Health (NIH 2P30DK072476)
  • Directorate for Biological Sciences
  • Nutrition Obesity Research Center, University of North Carolina (NIH 2P30‐DK072476)
  • National Institute of General Medical Sciences (P20GM103528, U54GM104940)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK072476)
  • National Center for Complementary and Integrative Health (P50AT002776)
Topics
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
Keywords
Artemisia scoparia, anti-inflammatory activity, adipocytes, macrophages, pancreatic beta cells, NF-κB signaling, ERK signaling, TNF-α, IL-1β, DBC1, FABP4, insulin sensitivity, metabolic disorders, high-fat feeding, ethanolic plant extract
MeSH terms
Animals, Anti-Inflammatory Agents, Disease Models, Animal, Humans, Inflammation, Macrophages, Transfection, Adipocytes, Artemisia, Scoparia, Insulin-Secreting Cells, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review